|
Market Closed -
Nasdaq
23:00:00 02/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 12.20 USD | -2.52% |
|
-7.26% | +49.21% |
Company Valuation: ORIC Pharmaceuticals, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 578.9 | 264.8 | 501.9 | 569.5 | 796.6 | 1,265 | - | - |
| Change | - | -54.26% | 89.55% | 13.47% | 39.89% | 58.8% | - | - |
| Enterprise Value (EV) | 578.9 | 264.8 | 266.8 | 569.5 | 751 | 1,265 | 1,265 | 1,265 |
| Change | - | -54.26% | 0.78% | 113.42% | 31.87% | 68.46% | 0% | 0% |
| P/E | -7.1x | -2.62x | -4.69x | -4.41x | -5.56x | -8.02x | -7.16x | -6.59x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | -0.3x | 0.4x | 0.66x | 0.3x | -2.29x | -0.6x | -0.76x |
| Capitalization / Revenue | - | - | - | - | - | - | - | 413x |
| EV / Revenue | - | - | - | - | - | - | - | 413x |
| EV / EBITDA | -0x | -0x | -0x | -0x | -0x | -7.84x | -7.64x | -8.85x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -7.06x | -6.04x | -5.3x |
| EV / FCF | -0x | -0x | -0x | -0x | -0x | -9.37x | -7.51x | -6.22x |
| FCF Yield | -10.4% | -29.2% | -17.2% | -20% | -14% | -10.7% | -13.3% | -16.1% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -2.07 | -2.25 | -1.96 | -1.83 | -1.47 | -1.521 | -1.705 | -1.852 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | - | 3.064 |
| EBITDA 1 | -77.97 | -90.8 | -109.7 | -141.8 | -141.8 | -161.4 | -165.6 | -143 |
| EBIT 1 | -78.87 | -91.77 | -110.8 | -142.9 | -143 | -179.1 | -209.6 | -238.7 |
| Net income 1 | -78.72 | -89.12 | -100.7 | -127.8 | -129.5 | -166.6 | -200.3 | -239.6 |
| Net Debt | - | - | -235 | - | -45.67 | - | - | - |
| Reference price 2 | 14.70 | 5.89 | 9.20 | 8.07 | 8.18 | 12.20 | 12.20 | 12.20 |
| Nbr of stocks (in thousands) | 39,382 | 44,953 | 54,552 | 70,567 | 97,389 | 103,653 | - | - |
| Announcement Date | 3/21/22 A | 3/16/23 A | 3/11/24 A | 2/18/25 A | 2/23/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.02x | - | - | -.--% | 1.27B | |
| 21.73x | 7.71x | 15.48x | 1.37% | 74.16B | |
| 29.82x | 8.57x | 26.7x | 0.04% | 57.39B | |
| 32.98x | 5.93x | 17.77x | 0.98% | 47.64B | |
| -21.31x | 230.81x | -22.97x | -.--% | 44.29B | |
| 33.26x | 3.23x | 13.97x | -.--% | 42.5B | |
| 46.77x | 5.41x | 29.66x | -.--% | 40.71B | |
| 27.63x | 7.93x | 20.48x | 0.41% | 30.97B | |
| 32.99x | 7.05x | 18.3x | -.--% | 28.53B | |
| -15.1x | 5.68x | -7.14x | -.--% | 24.34B | |
| Average | 18.08x | 31.37x | 12.47x | 0.28% | 39.18B | |
| Weighted average by Cap. | 22.17x | 32.04x | 13.55x | 0.42% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ORIC Stock
- Valuation ORIC Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
